Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05705193 · ClinicalTrials.gov registry record · NA

Brain-Training Treatment for Long COVID in Older Adults

A NA study of Post-Acute COVID-19 Syndrome, sponsored by UConn Health.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05705193 is a NA study of Post-Acute COVID-19 Syndrome that is actively recruiting participants, run by UConn Health. The registered enrollment target is 40 participants, below the 841-participant average among 14 other Post-Acute COVID-19 Syndrome trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05705193, a NA study of Post-Acute COVID-19 Syndrome, is actively recruiting participants, sponsored by UConn Health.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This research is being done to collect preliminary data on the potential of computerized "brain-training" exercises for treating Long COVID symptoms in older adults. The investigators hypothesize that computerized brain-training will be an acceptable and feasible intervention for treating Long COVID symptoms in older adults. The investigators also expect to provide initial evidence that computerized brain-training has potential for improving thinking, mood, and other aspects of everyday functioning in older adults with Long COVID.

Interventions

  • OTHER NeuroFlex (computerized gamified tasks)

Study Locations (1)

Connecticut

  • UConn Health - Farmington

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-04-07
Est. Completion 2026-06-30
Phase NA

Sponsor

UConn Health

178 total trials

What the Registry Record Tells You About NCT05705193

The ClinicalTrials.gov registry entry for NCT05705193 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 841-participant average among 14 other Post-Acute COVID-19 Syndrome trials with a reported enrollment target (95% lower). The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Post-Acute COVID-19 Syndrome appearing as the primary indexed condition, and to 1 intervention - of which NeuroFlex (computerized gamified tasks) is the first listed.

NCT05705193 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT05705193 about?

NCT05705193 is a clinical study titled "Brain-Training Treatment for Long COVID in Older Adults". This research is being done to collect preliminary data on the potential of computerized "brain-training" exercises for treating Long COVID symptoms in older adults. The investigators hypothesize that computerized brain-training will be an acceptable and feasible intervention for treating Long COVID...

What is the current status of trial NCT05705193?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-04-07. Estimated completion is 2026-06-30.

What conditions does trial NCT05705193 study?

This clinical trial studies the following conditions: Post-Acute COVID-19 Syndrome.

What interventions are being tested in trial NCT05705193?

The interventions under investigation include: NeuroFlex (computerized gamified tasks) (OTHER).

Who is sponsoring clinical trial NCT05705193?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05705193 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post-Acute COVID-19 Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.